The Cuban Center for Genetic Engineering and Biotechnology (CIGB) ratified that the Abdala anti-Covid-19 vaccine demonstrated its safety, efficacy and well-tolerance in the fight against the pandemic.
Abdala vaccine is safe, well tolerated and very effective”, highlighted the CIGB in a message on the social network Twitter.
The Cuban Abdala vaccine is the first anti-Covid-19 immunogen in Latin America and the Caribbean.
Since July 2021, the drug has been authorized for emergency use by the national regulatory entity, after demonstrating an efficacy of 92.28 percent in the prevention of symptomatic disease and an effectiveness of 90 percent in seriously ill patients affected by the disease. coronavirus SARS-CoV-2.
It also showed a 99.15 percent increase in antibodies in volunteers aged three to 11 years and 98.28 percent in those aged 12 to 18.
On the other hand, the Abdala vaccine, over time, maintains its safety, effectiveness and immune response against Covid-19, which confirms its suitability for booster doses.
Countries like Venezuela, Nicaragua, Iran and Vietnam administer Cuban vaccines to their population.
